Title

Author(s)

Citation

Text Link

Exposure-time-varying hazard function ratios in case-control studies of drug effects.

Guess HA.

Pharmacoepidemiology and Drug Safety 2006; 2:81-92.

abstract

Harmful medication errors in children: A five-year analysis of data from USP's MEDMARX program.

Hicks RW, Becker SC, Cousins DD.

J Pediatr Nurs 2006; 21(4):290-8.

abstract

Continuous Subcutaneous Glucose Monitoring in Pediatric Type 1 Diabetes Mellitus: A Single-Blind, Randomized Controlled Trial.

Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Calikoglu AS.

Pediatric Diabetes 2006; 7(3):159-164.

abstract

New Solid Phase Extraction Method for Determination of Mycophenolic Acid and Mycophenolic Acid Glucuronide in Human Plasma: 21.

Cox SL, Cabovska B, Vinks AA.

Therapeutic Drug Monitoring 2005; 27(2):215-216. Abstract.

Use Of An Emergency Department Discharge Database For Drug-Induced Anaphylaxis Surveillance Among Pediatric Patients.

D'Aloisio AA, Ringel-Kulka T, Waller AE, West SL, Bordley WC.

Pharmacoepidemiol Drug Safety 2005; 14(Suppl 2):S200. Abstract.

Vitamin D Supplementation Practices of U.S. Pediatricians and Family Practitioners.

Davenport ML, Kang M, Calikoglu AS.

Pediatric Research 2005; 57 (suppl 1). 

Preventing medication errors in pediatrics.

Hicks RW.

Outpatient Surgery Magazine 2005 (April); 78-79.

Continuous Subcutaneous Glucose Monitoring in Pediatric Type 1 Diabetes Mellitus: A Single-Blind, Randomized Controlled Trial. 

Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Calikoglu AS.

Pediatric Research 2005; 57 (suppl 1).  Abstract.

Medication errors involving pediatric patients.

Santell JP, Hicks RW.

Joint Commission Journal on Quality and Patient Safety 2005; 31(6):348-53.

Cost-effectiveness of Therapeutic Drug Monitoring: A Systematic Review.

Touw DJ, Neef C, Thomson AH, Vinks AA.  Cost-Effectiveness of Therapeutic Drug Monitoring Committee of the International Association for Therapeutic Drug Monitoring and Clinical Toxicology.

Therapeutic Drug Monitoring 2005; 27(1):10-7.

abstract

Medication errors in the LDRP: identifying common errors through MEDMARX reporting.

Beyea SC, Kobokovich LJ, Becker SC, Hicks RW.

AWHONN Lifelines 2004; 8(2):130-140.

Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755.

Bos AM, Boom K, Vinks AA, Boezen HM, Wanders J, Dombernovsky P, Aamdal S, de Vries EG, Uges DR.

Cancer Chemother Pharmacol 2004; 54(1):64-70.

abstract

Pediatrician patterns of prescribing vitamin supplementation for infants: do they contribute to rickets?

Davenport ML, Uckun A, Calikoglu AS.

Pediatrics 2004; 113(1 pt 1):179-80. Letter.

MEDMARX 5th anniversary data report. A chartbook of findings and trends, 1999 - 2003.

Hicks RW, Santell JP, Cousins DD, Williams RL.

United States Pharmacopeia Center for the Advancement of Patient Safety. Rockville, MD. 2004.  

Activities of cytochrome P450 1A2, N-acetyltransferase 2, xanthine oxidase, and cytochrome P450 2D6 are unaltered in children with cystic fibrosis.

Kennedy MJ, Scripture CD, Kashuba AD, Scott CS, Gaedigk A, Kearns GL.

Clin Pharmacol Ther 2004; 75(3):163-71. Erratum in: Clin Pharmacol Ther 2004; 75(6):579.

abstract

Comparison of various urine collection intervals for caffeine and dextromethorphan phenotyping in children.

Kennedy MJ, Abdel-Rahman SM, Kashuba AD, Leeder JS.

J Clin Pharmacol 2004; 44(7):708-14.

abstract

Medication Errors.

Lambert GH, Sturgill MG, Cousins DD.

In Yaffe SJ and Aranda JV (eds.), Neonatal and Pediatric Pharmacology Therapeutic Principles in Practice, 3rd Edition, 2004; 823-832.  Philadelphia: Lippincott, Williams, and Wilkins.

USP drug safety review: pediatric population requires vigilance to ensure safety.

Santell JP, Cousins DD, Hicks RW, Protzel MM.

Drug Topics 2004; 148:HSE14.

full article

Summary of Recent Cases: Broselow® Tape Changes.

U.S. Pharmacopeia.

Practitioner's Reporting News August 31, 2004. 

full article

Therapeutic Drug Monitoring.

Vinks AA, Walson PD.

In Yaffe SJ and Aranda JV (eds.), Neonatal and Pediatric Pharmacology Therapeutic Principles in Practice, 3rd Edition, 2004; 99-110. Philadelphia: Lippincott, Williams, and Wilkins.

Direct cost analysis of palivizumab in a cohort of at-risk children: evidence from North Carolina Medicaid Program.

Wegner S, Jacobson Vann J, Liu G, Byrns P, Cypra C, Campbell W, Stiles A.

Pediatrics 2004; 114(6):1612-1619.

abstract

Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis.

Brown SA, Ontjes DA, Lester GE, Lark RK, Hensler MB, Blackwood AD, Caminiti MJ, Backlund DC, Aris RM.

Osteoporos Int 2003; 14(5):442-9.  

abstract

Prophylactic vitamin D supplementation.

Calikoglu A, Davenport M.

Endocrine Development 2003; 6:233-58. Review. 

Improving communication of drug risks to prevent patient injury: proceedings of a workshop.

Campbell WH, Califf RM.

Pharmacoepidemiology and Drug Safety 2003; 12(3):183-194.  

abstract

Risk assessment of drugs, biologics and therapeutic devices: present and future issues.

Centers for Education and Research on Therapeutics Risk Assessment Workshop.

Pharmacoepidemiol Drug Safety 2003; 12(8):653-62.

abstract

Population model-based interpretation on pediatric nelfinavir therapeutic drug.

Cox S, Walson PD, Vinks AA.

Therapeutic Drug Monitoring 2003; 25 (4);521. Abstract.

A randomized controlled trial of a drug use review intervention for antibiotics medications for otitis media.

Lee Y, Ayar-Krishnan A, Cristensen DB.

Value in Health 2003; 6(3):182. Abstract.

USP drug safety review: the dangers associated with vaccinations.

Santell JP, Cousins DD, Hicks R.

Drug Topics October 20 2003; 147:HSE16.

full article

Medication errors: experience of the United States Pharmacopeia (USP) MEDMARX reporting system.

Santell JP, Hicks RW, McMeekin J, Cousins DD.

Journal of Clinical Pharmacology 2003; 43(7):760-7.

abstract

Error-Avoidance Recommendations for Medications Used in Pediatric Populations. 

U.S. Pharmacopeia. 

U.S. Pharmacopeia Web Site.  April 2003.

full article

Sirolimus TDM in the non-controlled clinical environment.

Vinks AA, Alloway RR, Claridge T, Trove J, Woodle ES.

Therapeutic Drug Monitoring 2003; 25(4):507. Abstract.

Clinical use of a simultaneous HPLC assay for indinavir, saquinavir, ritonavir, and nelfinavir in children and adults. 

Walson PD, Cox S, Utkin I, Gerber N, Crim L, Brady M, Koranyi K.

Therapeutic Drug Monitoring 2003; 25(5):650-656.

abstract

ADHD:  Caring for Children with ADHD:  A Resource Toolkit for Clinicians. 

American Academy of Pediatrics and the National Initiative for Children's Healthcare Quality. 

Cambridge, MA 2002.

toolkit web site

The impact of antibiotic selection on treatment outcomes for acute otitis media.

Ayyar-Krishnan A, Christensen DB.

Value in Health 2002; 5(3):261. Abstract.

Outcomes research and emergency medical services for children: domains, challenges, and opportunities. 

Bordley WC.

Ambulatory Pediatrics 2002; 2(4 Suppl):306-10.     

abstract

Agency for Healthcare Research and Quality.

Campbell W, Sleath B, Bosco L.

Encyclopedia of Clinical Pharmacy Oct 31 2002; 35-38.

Pediatrician patterns of prescribing vitamin supplementation for infants: do they contribute to rickets?

Davenport ML, Uckun A, Calikoglu AS.

Pediatr Res 2002; 51(4):663. Abstract

The potential impact of measuring healthcare quality on pharmaceutical-related costs and outcomes.

Roper WL, Hodlewsky RT, Tilson H, Lohr KN, Campbell WH.

Disease Management and Health Outcomes 2002; 10(4):233-239.

abstract

Assessing health status and quality-of-life instruments:  Attributes and review criteria.

Scientific Advisory Committee of the Medical Outcomes Trust (Kathleen N. Lohr, Corresponding Author).

Quality of Life Research 2002; 11:193-205.   Review.

abstract

Ambulatory use of psychotropics by employer-insured children and adolescents in a national managed care organization.

Shatin D, Drinkard C.

Ambulatory Pediatrics 2002; 2:111-119. 

abstract

Medication errors in children. A descriptive summary of medication error reports submitted to the United States Pharmacopeia.

Cowley E, Williams R, Cousins D.

Curr Ther Res 2001; 62: 627-640.

abstract

Assessment of hepatic metabolism in children with cystic fibrosis.

Kennedy MJ, Gotschall RR, Kashuba A, Scott CS, Scripture CD, Kearns GL.

Clin Pharmacol Ther 2001; 69:38 (abstract PII-24).

Methodologic challenges in health services research in the pediatric population.

Lohr KN, Dougherty D, Simpson L.

Ambulatory Pediatrics 2001; 1(1):36-8. 

The Centers for Education and Research on Therapeutics (CERTs) program in the US.

Lohr KN, Tolleson-Rinehart S.

Conference Proceedings 2001; 22-24.

Physician-patient communication about over-the-counter medications.

Sleath B, Rubin RH, Campbell W, Gwyther L, Clark T.

Social Science Medicine 2001; 53(3):357-369.

abstract

Nutritional rickets in African American breast-fed infants.

Kreiter SR, Schwartz RP, Kirkman HN Jr, Charlton PA, Calikoglu AS, Davenport ML.

Journal of Pediatrics 2000; 137(2):153-7.  

abstract

Vitamin D depletion and replacement in patients with cystic fibrosis.

Ontjes DA, Lark RK, Lester GE, Hollis BW, Hensler MB, Aris RM. 

In Normal AW, Bouillon R, Thomasset M (eds.), Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects 2000; 893-896.  Riverside, CA: University of California at Riverside Press.